Hochschulschrift
Identification of genomic alterations in castration resistant prostate cancer using next generation sequencing
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
21 cm
- Umfang
-
123 S.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Bonn, Univ., Diss., 2013
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Menon, Roopika
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Menon, Roopika
Ähnliche Objekte (12)
Identification of Genomic Alterations in Castration Resistant Prostate Cancer using Next Generation Sequencing
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients
Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer
Targeting molecular resistance in castration-resistant prostate cancer
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Osteoclasts directly influence castration-resistant prostate cancer cells
Effect of simvastatin on castration-resistant prostate cancer cells
Ureter metastatic castration-resistant prostate cancer: a case report
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)
Identification of Genomic Alterations in Castration Resistant Prostate Cancer using Next Generation Sequencing
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients
Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer
Targeting molecular resistance in castration-resistant prostate cancer
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Osteoclasts directly influence castration-resistant prostate cancer cells
Effect of simvastatin on castration-resistant prostate cancer cells
Ureter metastatic castration-resistant prostate cancer: a case report
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)
Identification of Genomic Alterations in Castration Resistant Prostate Cancer using Next Generation Sequencing
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients
Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer
Targeting molecular resistance in castration-resistant prostate cancer
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Osteoclasts directly influence castration-resistant prostate cancer cells
Effect of simvastatin on castration-resistant prostate cancer cells
Ureter metastatic castration-resistant prostate cancer: a case report
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends